Delivery Order SPE2DB20D9214-SPE2DB25FD4UE
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,025,980 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a ceiling value of $4,636.15 and a performance period ending on April 17, 2025. The contract was awarded on April 16, 2025 and is not set aside for any specific program....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,589.87 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a completion date of May 19, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,589.87, is for the supply of 10 mL vials of the TYPHIM VI 25 MCG/0.5 ML vaccine. The contract has a firm fixed price and an ultimate completion date of April 24, 2025. DMS Pharmaceutical Group Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $10,818.60 contract is for the delivery of 4,567,989,735 units of the vaccine TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The order has an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger $499,999,999 Indefinite...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $4,161.68 contract is for the delivery of 10 mL vials of the TYPHIM VI 25 MCG/0.5 ML vaccine. The contract is not associated with any set-aside designations. It is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to order a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $20,658.62 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a period of performance through December 19, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a specialized pharmaceutical product, with a ceiling value of $3,015.30 and a period of performance ending on February 18, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $9,363.10, is for the supply of Typhim VI 25 mcg/0.5 mL vial in 10 mL sizes. The contract has an ultimate completion date of August 16, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Typhim VI 25 mcg/0.5 mL vial, 10 mL, a vaccine product, with a ceiling value of $1,040.42 and a completion date of September 23, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,781.69, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group Inc. has a larger indefinite delivery contract (IDC) with the DLA under the...